<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35548336</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells.</ArticleTitle><Pagination><StartPage>872736</StartPage><MedlinePgn>872736</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">872736</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.872736</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes coronavirus disease (COVID-19) is one of the most serious global health crises in recent history. COVID-19 patient symptoms range from life-threatening to mild and asymptomatic, which presents unique problems in identifying, quarantining, and treating the affected individuals. The emergence of unusual symptoms among survivors, now referred to as "Long COVID", is concerning, especially since much about the condition and the treatment of it is still relatively unknown. Evidence so far also suggests that some of these symptoms can be attributed to vascular inflammation. Although famotidine, the commonly used histamine H2 receptor (H2R) blocker, was shown to have no antiviral activity, recent reports indicate that it could prevent adverse outcomes in COVID-19 patients. Histamine is a classic proinflammatory mediator, the levels of which increase along with other cytokines during COVID-19 infection. Histamine activates H2R signaling, while famotidine specifically blocks H2R activation. Investigating the effects of recombinant SARS-CoV-2 spike protein S1 Receptor-Binding Domain (Spike) on ACE2 expression in cultured human coronary artery endothelial cells, we found that the presence of histamine potentiated spike-mediated ACE2 internalization into endothelial cells. This effect was blocked by famotidine, protein kinase A inhibition, or by H2 receptor protein knockdown. Together, these results indicate that histamine and histamine receptor signaling is likely essential for spike protein to induce ACE2 internalization in endothelial cells and cause endothelial dysfunction and that this effect can be blocked by the H2R blocker, famotidine.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Raghavan and Leo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raghavan</LastName><ForeName>Somasundaram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leo</LastName><ForeName>M Dennis</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">angiotensin-converting enzyme-2</Keyword><Keyword MajorTopicYN="N">famotidine</Keyword><Keyword MajorTopicYN="N">histamine</Keyword><Keyword MajorTopicYN="N">spike</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35548336</ArticleId><ArticleId IdType="pmc">PMC9084361</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.872736</ArticleId><ArticleId IdType="pii">872736</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. (2020). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N. Engl. J. Med. 383, 120&#x2013;128. 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A., Calabrone L., Carlini V., Benedetto N., Lombardo M., Bruno A., et al. (2021). Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis. Front. Immunol. 12, 718136. 10.3389/fimmu.2021.718136</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.718136</ArticleId><ArticleId IdType="pmc">PMC8503675</ArticleId><ArticleId IdType="pubmed">34646263</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., Xia C., Olejnik J., White M. R., Napoleon M. A., Lotfollahzadeh S., et al. (2022). Extracellular Vimentin Is an Attachment Factor that Facilitates SARS-CoV-2 Entry into Human Endothelial Cells. Proc. Natl. Acad. Sci. 119, e2113874119. 10.1073/pnas.2113874119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballout R. A., Sviridov D., Bukrinsky M. I., Remaley A. T. (2020). The Lysosome: A Potential Juncture between SARS-CoV-2 Infectivity and Niemann-Pick Disease Type C, with Therapeutic Implications. Faseb j 34, 7253&#x2013;7264. 10.1096/fj.202000654R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000654R</ArticleId><ArticleId IdType="pmc">PMC7383733</ArticleId><ArticleId IdType="pubmed">32367579</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaess M., Kaiser L., Sauer M., Csuk R., Deigner H. P. (2020). COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Int. J. Mol. Sci. 21, 2020. 10.3390/ijms21144953</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21144953</ArticleId><ArticleId IdType="pmc">PMC7404102</ArticleId><ArticleId IdType="pubmed">32668803</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Caraffa A., Tet&#xe8; G., Gallenga C. E., Ross R., Kritas S. K., et al. (2020). Mast Cells Activated by SARS-CoV-2 Release Histamine Which Increases IL-1 Levels Causing Cytokine Storm and Inflammatory Reaction in COVID-19. J. Biol. Regul. Homeost Agents 34, 1629&#x2013;1632. 10.23812/20-2EDIT</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-2EDIT</ArticleId><ArticleId IdType="pubmed">32945158</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. (2021). Long Covid-Mechanisms, Risk Factors, and Management. BMJ 374, n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport B. J., Morrison T. E., Kedl R. M., Klarquist J. (2021). Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified Following Subunit Vaccination. J. Immunol. 206, 2503&#x2013;2507. 10.4049/jimmunol.2100195</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100195</ArticleId><ArticleId IdType="pmc">PMC8165008</ArticleId><ArticleId IdType="pubmed">33972373</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldanasory O. A., Eljaaly K., Memish Z. A., Al-Tawfiq J. A. (2020). Histamine Release Theory and Roles of Antihistamine in the Treatment of Cytokines Storm of COVID-19. Trav. Med Infect Dis 37, 1018742020. 10.1016/j.tmaid.2020.101874</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101874</ArticleId><ArticleId IdType="pmc">PMC7470786</ArticleId><ArticleId IdType="pubmed">32891724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennis M., Tiligada K. (2021). Histamine Receptors and COVID-19. Inflamm. Res. 70 (1), 67&#x2013;75. 10.1007/s00011-020-01422-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01422-1</ArticleId><ArticleId IdType="pmc">PMC7673069</ArticleId><ArticleId IdType="pubmed">33206207</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg D. E., Conigliaro J., Wang T. C., Tracey K. J., Callahan M. V., Abrams J. A. (2020). Famotidine Use Is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology 159, 1129&#x2013;e3. e1123. 10.1053/j.gastro.2020.05.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.053</ArticleId><ArticleId IdType="pmc">PMC7242191</ArticleId><ArticleId IdType="pubmed">32446698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki E., Anyfanti P., Gavriilaki M., Lazaridis A., Douma S., Gkaliagkousi E. (2020). Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr. Hypertens. Rep. 22, 63. 10.1007/s11906-020-01078-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-020-01078-6</ArticleId><ArticleId IdType="pmc">PMC7449866</ArticleId><ArticleId IdType="pubmed">32852642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R., Chatterjee S., Dubey S., Lavie C. J. (2020). Famotidine against SARS-CoV2: A Hope or Hype? Mayo Clin. Proc. 95, 1797&#x2013;1799. 10.1016/j.mayocp.2020.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.027</ArticleId><ArticleId IdType="pmc">PMC7275146</ArticleId><ArticleId IdType="pubmed">32753153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M. L., Lely A. T., Navis G., van Goor H. (2004). Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J. Pathol. 203, 631&#x2013;637. 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan R., Leo M. D., Muralidharan P., Mata-Daboin A., Yin W., Bulley S., et al. (2019). SUMO1 Modification of PKD2 Channels Regulates Arterial Contractility. Proc. Natl. Acad. Sci. U S A. 116, 27095&#x2013;27104. 10.1073/pnas.1917264116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917264116</ArticleId><ArticleId IdType="pmc">PMC6936352</ArticleId><ArticleId IdType="pubmed">31822608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z-L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19 (3), 141&#x2013;154. 10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Yang C., Xu X. F., Xu W., Liu S. W. (2020). Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19. Acta Pharmacol. Sin 41, 1141&#x2013;1149. 10.1038/s41401-020-0485-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0485-4</ArticleId><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo M. D., Peixoto-Nieves D., Yin W., Raghavan S., Muralidharan P., Mata-Daboin A., et al. (2021). TMEM16A Channel Upregulation in Arterial Smooth Muscle Cells Produces Vasoconstriction during Diabetes. Am. J. Physiol. Heart Circ. Physiol. 320, H1089&#x2013;h1101. 10.1152/ajpheart.00690.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00690.2020</ArticleId><ArticleId IdType="pmc">PMC7988758</ArticleId><ArticleId IdType="pubmed">33449847</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo M. D., Zhai X., Muralidharan P., Kuruvilla K. P., Bulley S., Boop F. A., et al. (2017). Membrane Depolarization Activates BK Channels through ROCK-Mediated &#x3b2;1 Subunit Surface Trafficking to Limit Vasoconstriction. Sci. Signal. 10. 10.1126/scisignal.aah5417</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aah5417</ArticleId><ArticleId IdType="pmc">PMC5812274</ArticleId><ArticleId IdType="pubmed">28487419</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo M. D., Zhai X., Yin W., Jaggar J. H. (2018). Impaired Trafficking of Beta1 Subunits Inhibits BK Channels in Cerebral Arteries of Hypertensive Rats. Hypertension 72 (3), 765&#x2013;775. 10.1161/HYPERTENSIONAHA.118.11147</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.11147</ArticleId><ArticleId IdType="pmc">PMC6202242</ArticleId><ArticleId IdType="pubmed">30012867</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffredo M., Lucero H., Chen D-Y., O&#x2019;Connell A., Bergqvist S., Munawar A., et al. (2021). The In-Vitro Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication. Sci Rep 11, 5433. 10.1038/s41598-021-84782-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84782-w</ArticleId><ArticleId IdType="pmc">PMC7940615</ArticleId><ArticleId IdType="pubmed">33686143</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone R. W., Tisdall P., Fremont-Smith P., Liu Y., Huang X. P., White K. M., et al. (2021). COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front. Pharmacol. 12, 633680. 10.3389/fphar.2021.633680</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.633680</ArticleId><ArticleId IdType="pmc">PMC8021898</ArticleId><ArticleId IdType="pubmed">33833683</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. (2020). How COVID-19 Can Damage the Brain. Nature 585, 342&#x2013;343. 10.1038/d41586-020-02599-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02599-5</ArticleId><ArticleId IdType="pubmed">32934351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mather J. F., Seip R. L., McKay R. G. (2020). Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients with COVID-19. Am. J. Gastroenterol. 115, 1617&#x2013;1623. 10.14309/ajg.0000000000000832</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000832</ArticleId><ArticleId IdType="pmc">PMC7473796</ArticleId><ArticleId IdType="pubmed">32852338</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell A. J., Ding J., You Y., Dong Z., Chehade H., Alvero A., et al. (2021). Identification of Key Signaling Pathways Induced by SARS-CoV2 that Underlie Thrombosis and Vascular Injury in COVID-19 Patients. J. Leukoc. Biol. 109, 35&#x2013;47. 10.1002/JLB.4COVR0920-552RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4COVR0920-552RR</ArticleId><ArticleId IdType="pmc">PMC7753679</ArticleId><ArticleId IdType="pubmed">33242368</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken I. R., Saginc G., He L., Huseynov A., Daniels A., Fletcher S., et al. (2021). Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells. Circulation 143, 865&#x2013;868. 10.1161/CIRCULATIONAHA.120.052824</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052824</ArticleId><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mura C., Preissner S., Nahles S., Heiland M., Bourne P. E., Preissner R. (2021). Real-world Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients. Signal. Transduct Target. Ther. 6, 267. 10.1038/s41392-021-00689-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00689-y</ArticleId><ArticleId IdType="pmc">PMC8278809</ArticleId><ArticleId IdType="pubmed">34262013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens J. S., et al. (2021). Post-acute COVID-19 Syndrome. Nat. Med. 27, 601&#x2013;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento Conde J., Schutt W. R., Gorbunova E. E., Mackow E. R. (2020). Recombinant ACE2 Expression Is Required for SARS-CoV-2 to Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses. mBio 11, e03185&#x2013;20. 10.1128/mBio.03185-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03185-20</ArticleId><ArticleId IdType="pmc">PMC7751258</ArticleId><ArticleId IdType="pubmed">33310781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo G. J., Magro C., Shaffer T., Awad H., Suster D., Mikhail S., et al. (2021). Endothelial Cell Damage Is the central Part of COVID-19 and a Mouse Model Induced by Injection of the S1 Subunit of the Spike Protein. Ann. Diagn. Pathol. 51, 151682. 10.1016/j.anndiagpath.2020.151682</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S., Kenchappa D. B., Leo M. D. (2021). SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins that Maintain Endothelial Barrier Integrity. Front. Cardiovasc. Med. 8, 687783. 10.3389/fcvm.2021.687783</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.687783</ArticleId><ArticleId IdType="pmc">PMC8225996</ArticleId><ArticleId IdType="pubmed">34179146</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A. V., Jayadevan R., Sashidharan S. (2021). Long COVID: An Overview. Diabetes Metab. Syndr. 15, 869&#x2013;875. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E. M., Logsdon A. F., Hansen K. M., Williams L. M., Reed M. J., Baumann K. K., et al. (2021). The S1 Protein of SARS-CoV-2 Crosses the Blood-Brain Barrier in Mice. Nat. Neurosci. 24, 368&#x2013;378. 10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethia R., Prasad M., Jagannath S., Nischal N., Soneja M., Garg P. Shalimar (2020). Efficacy of Famotidine for COVID-19: A Systematic Review and Meta-Analysis. medRxiv. 10.1101/2020.09.28.20203463</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.28.20203463</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., et al. (2020). Cell Entry Mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U S A. 117, 11727&#x2013;11734. 10.1073/pnas.2003138117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H. K., Libby P., Ridker P. M. (2021). COVID-19 - A Vascular Disease. Trends Cardiovasc. Med. 31, 1&#x2013;5. 10.1016/j.tcm.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A. J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A. S., et al. (2020). Endothelial Cell Infection and Endotheliitis in COVID-19. Lancet 395, 1417&#x2013;1418. 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou A. G., Kotanidou A., Dimopoulou I., Orfanos S. E. (2020). Endothelial Damage in Acute Respiratory Distress Syndrome. Int. J. Mol. Sci. 21, 8793. 10.3390/ijms21228793</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228793</ArticleId><ArticleId IdType="pmc">PMC7699909</ArticleId><ArticleId IdType="pubmed">33233715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J. U. G., Bojkova D., Shumliakivska M., Lux&#xe1;n G., Nicin L., Aslan G. S., et al. (2021). Increased Susceptibility of Human Endothelial Cells to Infections by SARS-CoV-2 Variants. Basic Res. Cardiol. 116, 42. 10.1007/s00395-021-00882-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00882-8</ArticleId><ArticleId IdType="pmc">PMC8256413</ArticleId><ArticleId IdType="pubmed">34224022</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A. C., Park Y. J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281&#x2013;e6. e286. 10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W. J., Rhodes A., Cheng A. C., Peacock S. J., Prescott H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 324, 782&#x2013;793. 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Penninger J. M., Li Y., Zhong N., Slutsky A. S. (2020). Angiotensin-converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target. Intensive Care Med. 46, 586&#x2013;590. 10.1007/s00134-020-05985-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05985-9</ArticleId><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Tecson K. M., McCullough P. A. (2020). Endothelial Dysfunction Contributes to COVID-19-Associated Vascular Inflammation and Coagulopathy. Rev. Cardiovasc. Med. 21, 315&#x2013;319. 10.31083/j.rcm.2020.03.126</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2020.03.126</ArticleId><ArticleId IdType="pubmed">33070537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Tecson K. M., McCullough P. A. (2021). Role of Endothelial Cell Receptors in the Context of SARS-CoV-2 Infection (COVID-19). Baylor Univ. Med. Cent. Proc. 34, 262&#x2013;268. 10.1080/08998280.2021.1874231</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2021.1874231</ArticleId><ArticleId IdType="pmc">PMC7852287</ArticleId><ArticleId IdType="pubmed">33664552</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. (2020). Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 202, 756&#x2013;759. 10.1164/rccm.202001-0179LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202001-0179LE</ArticleId><ArticleId IdType="pmc">PMC7462411</ArticleId><ArticleId IdType="pubmed">32663409</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>